NCT02532166

Brief Summary

The lichen planus is a mucocutaneous disease of unknown etiology with an incidence of 1-2%, that affects in 30-70% of cases either the mucosa of the mouth, or partly in combination with infection of the skin, the oral with his known premalignant potential in up to 2-3% predisposed to the development of an oral squamous cell carcinoma.In rare cases, there is also an manifestation of the lining of the esophagus, which can then be associated with symptomatic strictures of the esophagus. The value of moreover increasingly established endoscopic imaging procedures are investigated as well as data of the natural long-term outcome in esophageal lichen planus infestation especially in view of malignant transformation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

August 17, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 25, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

August 25, 2015

Status Verified

August 1, 2015

Enrollment Period

3.9 years

First QC Date

August 17, 2015

Last Update Submit

August 24, 2015

Conditions

Keywords

narrow band imagingChromoendoscopyLugol

Outcome Measures

Primary Outcomes (1)

  • Value of additional endoscopic enhancing imaging methods for detection of esophageal lichen planus.

    3-5 years

Secondary Outcomes (1)

  • Natural long-term incidence of esophageal lichen planus in patients with known oral lichen.

    3-5

Study Arms (1)

Esophageal lichen planus

OTHER

White light endoscopy compared to narrow band imaging and chromoendoscopy with Lugol for detection of esophageal lichen.

Other: Esophageal lichen planus

Interventions

White light endoscopy compared to narrow band imaging and Lugol for detection of esophageal lichen.

Esophageal lichen planus

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Known lichen planus of the oral mucosa

You may not qualify if:

  • Severe cardiopulmonary disease - ASA (American Society of Anaesthesiology) class \> III
  • Antisecretory and nonsteroidal anti-inflammatory medication within the last month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Medicine

Bochum, 44892, Germany

RECRUITING

Klinikum Agness Karll Laatzen

Laatzen, 30880, Germany

RECRUITING

Related Publications (1)

  • Quispel R, van Boxel OS, Schipper ME, Sigurdsson V, Canninga-van Dijk MR, Kerckhoffs A, Smout AJ, Samsom M, Schwartz MP. High prevalence of esophageal involvement in lichen planus: a study using magnification chromoendoscopy. Endoscopy. 2009 Mar;41(3):187-93. doi: 10.1055/s-0028-1119590. Epub 2009 Mar 11.

    PMID: 19280529BACKGROUND

MeSH Terms

Conditions

Lichen Planus

Condition Hierarchy (Ancestors)

Lichenoid EruptionsSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Andrea Riphaus, PD Dr

    Department of Medicine, KRH Laatzen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andrea Riphaus, PD MD

CONTACT

Pohl Michael, MF

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PD Dr. Andrea Riphaus

Study Record Dates

First Submitted

August 17, 2015

First Posted

August 25, 2015

Study Start

January 1, 2012

Primary Completion

December 1, 2015

Study Completion

December 1, 2016

Last Updated

August 25, 2015

Record last verified: 2015-08

Locations